Although both VISTA and programmed cell death receptor 1 (PD-1) are immune checkpoint proteins that inhibit T cell activation, VISTA and PD-L1/PD-1 pathways independently control tumor-specific T-cell responses (13). The gene discussed is VSIR; the disease is neoplasm.